Relationship between multifunctional protein 'clusterin' and Alzheimer disease

Neurobiology of Aging

Volumn 17, Issue 5, 1996, Pages 717-722

  Choi Miura, Nam Ho ^b   Oda, Tomiichiro ^a  

^a DAIICHI SANKYO CO   (Japan)

^b NONE

Author keywords

Alzheimer disease; Apo E; Apo J; CLI; Clusterin; Complement; SGP 2; SP 40,40; T64; Amyloid protein

Indexed keywords

AMYLOID BETA PROTEIN; CLUSTERIN;

ALZHEIMER DISEASE; COMPLEMENT SYSTEM; HUMAN; NERVE DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0030250394     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(96)00106-6     Document Type: Review

References (76)

1. 1. Behl, C.; Davis, J. B.; Lesley, R.; Schubert, D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827; 1994.
2. 2. Bertrand, P.; Poirier, J.; Oda, T.; Finch, C. E.; Pasinetti, G. M. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Mol. Brain Res. 33:174-178;1995.
3. 3. Buttyan, R.; Olsson, C. A.; Pintar, J.; Chang, C.; Bandyk, M.; Ng, P.-Y.; Sawczuk, I. S. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol. Cell. Biol. 9:3473-3481; 1989.
4. 4. Choi, N.-H.; Mazda, T.; Tomita, M. A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes. Mol. Immunol. 26:835-840; 1989.
5. 5. Choi, N.-H.; Tobe, T.; Hara, K.; Yoshida, H.; Tomita, M. Sandwich ELISA assay for quantitative measurement of SP-40,40 in seminal plasma and serum. J. Immunol. Methods 131:159-163; 1990.
6. 6. Choi-Miura, N.-H.; Ihara, Y.; Fukuchi, K.; Takeda, M.; Nakano, Y.; Tobe, T.; Tomita, M. SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol. Berl. 83:260-264; 1992.
7. 7. Choi-Miura, N.-H.; Sakamoto, T.; Tobe, T.; Nakano, Y.; Tomita, M. The role of HDL consisting of SP-40,40, apo A-1, and lipids in the formation of SMAC of complement. J. Biochem. 113:484-487; 1993.
8. 8. Choi-Miura, N.-H.; Takahashi, Y.; Nakano, Y.; Tobe, T.; Tomita, M. Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J). J. Biochem. 112:557-561; 1992.
9. 9. Collard, M. W.; Griswold, M. D. Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat sertoli cells. Biochemistry 26:3297-3303; 1987.
10. 10. Corder, E. H.; Saunders, A, M.; Strittmatter, W. J.; Schmechel, D. E.; Gaskell, P.C.; Small, G. W.; Roses, A.D.; Haines, J. L.; Pericak-Vance, M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923; 1993.
11. 11. Danik, M.; Chabot, J. G.; Hassan-Gonzalez, D.; Suh, M.; Quirion, R. Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization. J. Comp. Neurol. 334:209-227; 1993.
12. 12. Day, J. R.; Laping, N. J.; McNeill, T. H.; Schreiber, S. S.; Pasinetti, G.; Finch, C. E. Castration enhances expression of glial fibrillary acidic protein and sulfated glycoprotein-2 in the intact and lesion-altered hippocampus of the adult male rat. Mol. Endocrinol. 4:1995-2002; 1990.
13. 13. de Silva, H. V.; Harmony, J. A. K.; Stuart, W. D.; Gil, C. M.; Robbins, J. Apolipoprotein J: Structure and tissue distribution. Biochemistry 29:5380-5389; 1990.
14. 14. Diedrich, J. F.; Minnigan, H.; Carp, R. I.; Whitaker, J. N.; Race, R.; Frey, W.; Haase, A. T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65:4759-4768; 1991.
15. 15. Duguid, J. R.; Bohmont, C. W.; Liu, N.; Tourtellotte, W. W. Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7260-7264; 1989.
16. 16. Eikelenboom, P.; Hack, C. E,; Rozemuller, J. M.; Stam, F. C. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows. Arch. B. Cell. Pathol. Incl. Mol. Pathol. 56:259-262; 1989.
17. 17. Fritz, I. B.; Burdzy, K.; Setchell, B.; Blaschuk, O. Ram rete testis fluid contains a protein (clusterin) which influences cell-cell interactions in vitro. Biol. Reprod. 28:1173-1188; 1983.
18. 18. Fuson, K. S.; Boggs, L. N.; Baez, M.; McClure, D,; Corvalan, J.; Hepburn, D.; Becker, G.; May, P. C. Clusterin (Apo J) from a stably transfected mammalian cell line protects against amyloid (Aβ) neurotoxicity. Soc. Neurosci. Abstr. 20:1247; 1994.
19. 19. Gasque, P.; Fontaine, M.; Morgan, B. P. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154:4726-4733: 1995.
20. 20. Ghiso, J.; Matsubara, E.; Koudinov, A.; Choi-Miura, N.-H.; Tomita, M.; Wisniewski, T.; Frangione, B. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293:27-30; 1993.
21. 21. Glenner, G. G.; Wong, C. W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-890; 1984.
22. 22. Golabek, A.; Marques, M. A.; Lalowski, M.; Wisniewski, T. Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci. Lett. 191:79-82; 1995.
23. 23. Griffin, W. S.; Sheng, J. G.; Roberts, G. W.; Mrak, R. E. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54:276-281; 1995.
24. 24. Hartmann, K.; Rauch, J.; Urban, J.; Parczyk. K.; Diel, P.; Pilarsky, C.; Appel, D.; Haase, W.; Mann, K.; Weller, A.; Koch-Brandt, C. Molecular cloning of gp 80, a glycoprotein complex secreted by kidney cells in vitro and in vivo: A link to the reproductive system and to the complement cascade. J. Biol. Chem. 266:9924-9931; 1991.
25. 25. Jenne, D. E.; Tschopp, J. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: Identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc. Natl. Acad. Sci. USA 86:7123-7127; 1989.
26. 26. Jenne, D. E.; Tschopp, J. Clusterin: The intriguing guises of a widely expressed glycoprotein. Trends. Biochem. Sci. 17:154-159; 1992.
27. 27. Johnson, S. A.; Lampert-Etchells, M.; Pasinetti, G. M.; Rozovsky, I.; Finch, C. E. Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging 13:641-648; 1992.
28. 28. Kida, E.; Pluta, R.; Lossinsky, A. S.; Golabek, A. A.; Choi-Miura, N.-H.; Wisniewski, H, M.; Mossakowski, M. J. Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res. 674:341-346; 1995.
29. 29. Kounnas, M. Z.; Loukinova, E. B.; Stefansson, S.; Harmony, J. A. K.; Brewer, B. H.; Strickland, D. K.; Argraves, W. S. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem, 270:13070-3075; 1995.
30. 30. Lampert-Etchells, M.; McNeill, T. H.; Laping, N. J.; Zarow, C.; Finch, C. E.; May, P. C. Sulfated glycoprotein-2 is increased in rat hippocampus following entorhinal cortex lesioning. Brain. Res. 563:101-106; 1991.
31. 31. Lampert-Etchells, M.; Pasinetti, G. M.; Finch, C. E.; Johnson, S.A. Regional localization of cells containing complement C1q and C4 mRNAs in the frontal cortex during Alzheimer's disease. Neurodegeneration 2:111-121; 1993.
32. 32. Laping, N.J.; Morgan, T. E.; Nichols, N. R.; Rozovsky, L; Young-Chan, C. S.; Zarow, C.; Finch, C. E. Transforming growth factor-β1 induces neuronal and astrocyte genes: tubulin α1, glial fibrillary acidic protein and clusterin. Neuroscience 58:563-572; 1994.
33. 33. Lorenzo, A.; Yankner, B. A. α-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91:12243-12247; 1994.
34. 34. Masters, C. L.; Simms, G.; Weinman, N. A.; Multhaup, G.; McDonald, B. L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proc. Natl. Acad. Sci. USA 82:4245-4249; 1985.
35. 35. Matsubara, E.; Frangione, B.; Ghiso, J. Characterization of apolipoprotein J-Alzheimer s Aβ interaction. J. Biol. Chem. 270:7563-7567; 1995.
36. 36. May, P. C.; Finch, C. E. Sulfated glycoprotein 2: New relationships of this multifunctional protein to neurodegeneration. Trends. Neurosci. 15:391-396; 1992.
37. 37. May, P. C.; Lampert-Etchells, M.; Johnson, S. A.; Poirier, J.; Masters, J. N.; Finch. C. E. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron. 5:831-839; 1990.
38. 38. McGeer, P. L.; Akiyama, H.; Itagaki, S.; McGeer, E. G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 107:341-346; 1989.
39. 39. McGeer, P. L.; Kawamata, T.; Walker, D. G. Distribution of clusterin in Alzheimer brain tissue. Brain. Res, 579:337-341; 1992.
40. 40. McGeer, P. L.; Walker, D. G.; Akiyama, H.; Kawamata, T.; Guan, A. L.; Parker, C. J.; Okada, N.; McGeer, E, G. Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain. Res. 544:315-329; 1991.
41. 41. Michel, D.; Chabot, J. G.; Moyse, E.; Danik, M.; Quirion, R. Possible functions of a new genetic marker in central nervous system: The sulfated glycoprotein-2 (SGP-2). Synapse 11:105-111; 1992.
42. 42. Michel, D.; Gillet, G.; Volovitch, M.; Pessac, B.; Calothy, G.; Brun, G. Expression of a novel gene encoding a 51.5 kD precursor protein is induced by different retroviral oncogenes in quail neuroretinal cells. Oncogene Res. 4:127-136; 1989.
43. 43. Morgan, T. E.; Laping, N.J.; Rozovsky, I.; Oda, T.; Hogan T. H.; Finch, C. E.; Pasinetti, G. M. Clusterin expression by astrocytes is influenced by transforming growth factor b1 and heterotypic cell interactions. J. Neuroimmunol. 58:101-110; 1995.
44. 44. Murphy, B. F.; Saunders, J. R.; O'Bryan, M. K.; Kirszbaum, L.; Walker, I. D.; d'Apice, A. J. F. SP-40,40 is an inhibitor of C5b-6-initiated hemolysis. Int. Immunol. 1:551-554; 1989.
45. 45. Murphy, B. F.; Kirszbaum, L.; Walker, I. D.; d'Apice, A. J. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J. Clin. Invest. 81:1858-1864; 1988.
46. 46. Namba, Y.; Tomonaga, M.; Kawasaki, H.; Otomo, E.; Ikeda, K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain. Res. 541:163-166; 1991.
47. 47. O'Bryan, M. K.; Cheema, S. S.; Bartlett, P. F.; Murphy, B. F.; Pearse. M. J. Clusterin levels increase during neuronal development. J. Neurobiol. 24:421-432; 1993.
48. 48. Oda, T.; Pasinetti, G. M.; Osterburg, H. H.; Anderson, C.; Johnson, S. A.; Finch, C. E. Purification and characterization of brain clusterin. Biochem. Biophys. Res. Commun. 204:1131-1136; 1994.
49. 49. Oda, T.; Wals, P.; Osterburg, H. H.; Johnson, S. A.; Pasinetti, G. M.; Morgan, T. E.; Rozovsky, I.; Stine, W. B.; Snyder, S. W.; Holzman, T. F.; Krafft, G. A.; Finch, C. E. Clusterin (apo J) alters the aggregation of amyloid β-peptide (Aβ1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136:22-31; 1995.
50. 50. Palmer, D. J.; Christie, D. L. The primary structure of glycoprotein III from bovine adrenal medullary chromaffin granules: Sequence similarity with human serum protein-40,40 and rat sertori cell glycoprotein 2. J. Biol. Chem. 265:6617-6623; 1990.
51. 51. Pasinetti, G. M.; Finch, C. E. Sulfated glycoprotein-2 (SGP-2) mRNA is expressed in rat striatal astrocytes following ibotenic acid lesions. Neurosci. Lett. 130:1-4; 1991.
52. 52. Pasinetti, G. M.; Johnson, S. A.; Oda; T.; Rozovsky, I.; Finch, C. E. Clusterin (SGP-2): A multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J. Comp. Neurol. 339:387-400; 1994.
53. 53. Pasinetti, G. M.; Johnson, S. A.; Rozovsky, I.; Lampert-Etchells. M.; Morgan, D. G.; Gordon, M. N.; Morgan, T. E.; Willoughby, D.; Finch, C. E. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp. Neurol. 118:117-125; 1992.
54. 54. Pike, C. J.; Burdick, D.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1676-1687; 1993.
55. 55. Poirier, J.; Davignon, J.; Bouthillier, D.; Kogan, S.; Bertrand, P.; Gauthier, S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699; 1993.
56. 56. Poirier, J.; Hess, M,; May, P. C.; Pasinetti, G.; Finch, C. E. Astroglial gene expression during reactive synaptogenesis. In: Nagatsu, T., ed. Basic and therapeutic strategies in Alzheimer's and Parkinson's diseases. New York: Plenum Press; 1990:191-194.
57. 57. Rogers, J.; Cooper, N. R.; Webster, S.; Schultz, J.; McGeer, P. L.; Styren, S. D.; Civin, W. H.; Brachova, L.; Bradt, B.; Ward, P.; Lievervutg, I. Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89:10016-10020; 1992.
58. 58. Roher, A. E.; Lowenson, J. D.; Clarke, S.; Wolkow, C.; Wang, R.; Cotter, R. J.; Reardon, I. M.; Zurcher-Neely, H. A.; Heinrikson, R. L.; Ball, M. J.; et al. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268:3072-3083; 1993.
59. 59. Rozovsky, I.; Morgan, T. E.; Willoughby, D. A.; Dugichi-Djordjevich, M. M.; Pasinetti, G. M.; Johnson, S. A.; Finch, C. E. Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 62:741-758; 1994.
60. 60. Saunders, A. M.; Strittmatter, W. J.; Schmechel, D.; George-Hyslop, P. H.; Pericak-Vance, M. A.; Joo, S. H.; Rosi, B. L.; Gusella, J. F.; Crapper-MacLachlan, D. R.; Alberts, M. J.; et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472; 1993.
61. 61. Senut, M. C.; Jazat, F.; Choi, N.-H.; Lamour, Y. Protein SP40,40-like immunoreactivity in the rat brain: Progressive increase with age. Eur. J. Neurosci. 4:917-928; 1992.
62. 62. Seubert, P.; Vigo-Pelfrey, C.; Esch, F.; Lee, M.; Dovey, H.; Davis, D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindlehurst, C.; et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327; 1992.
63. 63. Shearman, M. S.; Ragan, C. I.; Iversen, L. L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA 91:1470-1474; 1994.
64. 64. Shoji, M.; Golde, T. E.; Ghiso, J.; Cheung, T. T.; Estus, S.; Shaffer, L. M.; Cai, X. D.; McKay, D. M.; Tintner, R.; Frangione, B.; et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258:126-129; 1992.
65. 65. Simmons, L. K.; May, P. C.; Tomaselli, K. J.; Rydel, R. E.; Fuson, K. S.; Brigham, E. F.; Wright, S.; Lieberburg, I.; Becker, G. W.; Brems, D. N.; et al. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45:373-379; 1994.
66. 66. Snyder, S. W.; Ladror, U. S.; Wade, W. S.; Wang, G. T.; Barrett, L. W.; Matayoshi, E. D.; Huffaker, H. J.; Krafft, G. A.; Holzman, T. F. Amyloid-β aggregation: Selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67:1216-1228; 1994.
67. 67. van der Wal, E. A.; Gomez-Pinilla, F.; Cotman, C. W. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4:69-72; 1993.
68. 68. Veerhuis, R.; van der Valk, P.; Janssen, L; Zhan, S. S.: Van Nostrand, W. E.; Eikelenboom, P. Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3. Virchows. Arch. 426:603-610; 1995.
69. 69. Whitson, J. S.; Glabe, C. G.; Shintani, E.; Abcar, A.; Cotman, C.W. β-Amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci. Lett. 110:319-324; 1990.
70. 70. Whitson, J. S.; Selkoe, D. J.; Cotman, C. W. Amyloid β protein enhances the survival of hippocampal neurons in vitro. Science 243: 1488-1490; 1989.
71. 71. Wisniewski, T.; Golabek, A.; Matsubara, E.; Ghiso, J.; Frangione, B. Apolipoprotein E: Binding to soluble Alzheimer's β-amyloid. Biochem. Biophys. Res. Commun. 192:359-365; 1993.
72. 72. Wu, E.; Brosnan, C. F.; Raine, C. S. SP-40,40 immunoreactivity in inflammatory CNS lesions displaying astrocyte/oligodendrocyte interactions. J. Neuropathol. Exp. Neurol. 52:129-134; 1993.
73. 73. Yankner, B. A.; Duffy, L. K.; Kirschner, D. A. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250:279-282; 1990.
74. 74. Zhan, S.-S.; Veerhuis, R.; Janssen, I.; Kamphorst, W.; Eikelenboom, P. Immunohistochemical distribution of the inhibitors of the terminal complement complex in Alzheimer's disease. Neurodegeneration 3: 111-117; 1994.
75. 75. Zlokovic, B. V.; Martel, C. L.; Mackic, J. B.; Matsubara, E.; Wisniewski, T.; McComb, J. G.; Frangione, B.; Ghiso, J. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem. Biophys. Res. Commun. 205:1431-1437; 1994.
76. 76. Zwain, I. H.; Grima, J.; Cheng, C. Y. Regulation of clusterin secretion and mRNA expression in astrocytes by cytokines. Mol. Cell. Neurosci. 5:229-237; 1994.